Table 1.

Adverse events reported in the 3 groups

	Donepezil (n = 25)	Rivastigmine (n = 25)	Galantamine (n = 25)
Nausea	3 (12.0)	2 (8.0)	1 (4.0)
Vomiting	2 (8.0)	1 (4.0)	0
Headache	1 (4.0)	1 (4.0)	1 (4.0)
Dizziness	0	1 (4.0)	1 (4.0)
Sedation	0	0	2 (8.0)
Skin problems	0	2 (8.0)	0
Anorexia	1 (4.0)	0	0
Agitation	0	0	1 (4.0)

Data are presented as number (%) of patients.